Marko Anderluh
Impact in
- Toxicology top 2%
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
- Immunology 27
- Galectins and Cancer Biology 13
- Immunotherapy and Immune Responses 10
-
- Glycosylation and Glycoproteins Research 26
- Cancer therapeutics and mechanisms 15
- Co-authors
- Urban Švajger (9 shared papers)Nataša Obermajer (6 shared papers)Tihomir Tomašič (33 shared papers)Andrija Šmelcerović (15 shared papers)Matjaž Jeras (3 shared papers)GORDANA KOCIC (10 shared papers)Katarina Tomović (7 shared papers)Nikola Minovski (13 shared papers)
- Journals
- ChemMedChem (9 papers)European Journal of Medicinal Chemistry (9 papers)Journal of Medicinal Chemistry (6 papers)Antibiotics (4 papers)ACS Medicinal Chemistry Letters (4 papers)
- Partner nations
- SloveniaSerbiaNetherlands
In The Last Decade
Marko Anderluh
101 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 104
- Toxicology 95
- Molecular Medicine 141
- Organic Chemistry 668
- Immunology 391
- Molecular Biology 1.2k
Countries citing papers authored by Marko Anderluh
This map shows the geographic impact of Marko Anderluh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Anderluh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Anderluh more than expected).
Fields of papers citing papers by Marko Anderluh
This network shows the impact of papers produced by Marko Anderluh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Anderluh. The network helps show where Marko Anderluh may publish in the future.
Co-authors
The 25 scholars most cited alongside Marko Anderluh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 211 | |
| 2 | 2017 | 113 | |
| 3 | 2015 | 97 | |
| 4 | 2009 | 69 | |
| 5 | 2018 | 68 | |
| 6 | 2008 | 58 | |
| 7 | 2021 | 57 | |
| 8 | 2016 | 56 | |
| 9 | 2016 | 54 | |
| 10 | 2020 | 51 | |
| 11 | 2005 | 49 | |
| 12 | 2021 | 45 | |
| 13 | 2008 | 44 | |
| 14 | 2012 | 42 | |
| 15 | 2004 | 39 | |
| 16 | 2015 | 39 | |
| 17 | 2010 | 35 | |
| 18 | 2022 | 33 | |
| 19 | 2018 | 32 | |
| 20 | 2021 | 31 |
About Marko Anderluh
Marko Anderluh is a scholar working on Immunology, Molecular Biology, Organic Chemistry, Molecular Medicine and Pharmacology, having authored 102 papers that have together received 2.1k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (26 papers), Carbohydrate Chemistry and Synthesis (15 papers), Cancer therapeutics and mechanisms (15 papers), Galectins and Cancer Biology (13 papers), Antibiotic Resistance in Bacteria (11 papers), Immunotherapy and Immune Responses (10 papers), Neuropeptides and Animal Physiology (8 papers) and Bioactive Compounds and Antitumor Agents (7 papers). The work is most often cited by research in Toxicology (95 citations), Molecular Medicine (141 citations), Organic Chemistry (668 citations), Immunology (391 citations) and Molecular Biology (1.2k citations). Marko Anderluh has collaborated with scholars based in Slovenia, Serbia and Netherlands. Frequent co-authors include Urban Švajger, Nataša Obermajer, Tihomir Tomašič, Andrija Šmelcerović, Matjaž Jeras, GORDANA KOCIC, Katarina Tomović, Nikola Minovski, D. Kikelj and Žiga Jakopin. Their work appears in journals such as ChemMedChem, European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Antibiotics and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.